Navigation Links
Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
Date:9/22/2008

Accelerated cloning of high-efficiency production cell lines may get new protein therapeutics to the clinic sooner and reduce production costs

SAN DIEGO, Sept. 22 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and commercialization of live-cell analysis and manipulation systems, announced today the launch of CellXpress, powered by the Company's proprietary laser-based system LEAP(TM). The automated system brings new improvements in speed, cost and optimal clone selection for cell line development. Biopharmaceutical teams developing manufacturing cell lines for potential medicines can now reduce the time required to get to clinical testing, decrease production costs of protein therapeutics and substantially increase the number of development projects which can be processed in parallel.

CellXpress can be purchased by customers directly from Cyntellect in the U.S. and Europe and from Cyntellect's distribution partner, Summit Pharmaceuticals, in Japan.

The CellXpress system exploits high-speed imaging of living cells combined with simultaneous laser elimination of undesired cells, leaving behind cells that are efficiently secreting biopharmaceutical proteins. The process is initiated by imaging thousands of cells per well to quantify the level of protein being secreted by each cell. This unique measurement is enabled by Cyntellect's proprietary in situ assay for capturing and labeling secreted protein around living individual cells. The best secreting cell is located in seconds within a pool of thousands of candidate cells, and once located; all other undesired cells are selectively eliminated with the laser leaving behind only the best cell. This purification results in a verified clone that is very likely to generate a highly secreting cell lines. The imaging and purification processes can be repeated hundreds of times an hour to enable scanning through millions of cells per day, often yielding hundreds of highly-secreting clones. In contrast, current manual and semi-automated approaches are able to screen through thousands of cells per day and often yield tens of clones following many weeks of growth and assessment.
The CellXpress system can provide significant benefits to customers by:

-- Yielding verified highly-secreting single-cell clones in less than 24

hours (vs. weeks)

-- Isolating ten-fold more highly secreting clones than traditional

methods

-- Selecting optimal clones based on real-time assessment of secretion,

growth and stability

-- Reducing time to confirmed highly-secreting clones by more than 50%

-- Delivering up to 90% reduction in labor and material costs

-- Enabling processing of multiple projects / cell lines in parallel

"The increasing pressures on bioprocess development teams to improve manufacturing productivity and shorten timelines have not been adequately addressed," said Fred Koller, Ph.D., Cyntellect's President and Chief Executive Officer. "Our goal with CellXpress is to provide a reliable, scalable and efficient product that customers can purchase and use in-house to empower significant productivity gains, while also helping get new potential drugs to market sooner."

Previously, CellXpress was available only as a fee for service from SAFC Biosciences. Now, customers can purchase the technology as a product directly from Cyntellect and its distributors allowing bioprocessing teams to harvest the productivity benefits of CellXpress as part of their in-house programs.

About Cyntellect

Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at http://www.cyntellect.com.


'/>"/>
SOURCE Cyntellect
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cyntellect to Collaborate With the Burnham Institute for Medical Research
2. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
3. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
4. Lena Chow, Veteran Biotech Marketer, Launches New Website
5. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
6. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
7. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
8. SACHEM Launches 2-D HPLC e-Learning Program : New e-Learning Program Teaches Scientists How to Better Analyze and Prove Product Purity Through Greater Sensitivity and Precision in Identification of Trace Components
9. Familybuilder Launches the Familybuilder Global Network at DEMOfall 08
10. SearchMedica Launches Practice Management Search Engine for Medical Professionals
11. BIOLOCK(TM) USA Launches Affordable Fingerprint door Locks for Homes and Offices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. ... patents, U.S. Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies ... well as hydrophobic nanocellulose compositions. In addition to these patents and U.S. ...
(Date:5/4/2016)... ... May 05, 2016 , ... ... support the National Stroke Association during National Stroke Awareness Month in May. ... Twitter pages throughout the month. CereScan will donate $1 up to a ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... ... 04, 2016 , ... PBI-Gordon Corporation is pleased to announce Doug Obermann has ... his career at PBI-Gordon in February 1988, after finishing his masters in agronomy from ... from customer service to national product manager, to helping develop, name and launch many ...
Breaking Biology Technology:
(Date:3/14/2016)... HANOVER , Allemagne, March 14, 2016 /PRNewswire/ ... http://www.apimages.com ) - --> - ... ) - --> ... les solutions biométriques, fournit de nouveaux lecteurs d,empreintes ... lecteur LF10 de DERMALOG sera utilisé pour produire ...
(Date:3/10/2016)... , March 10, 2016 ... market research report "Identity and Access Management Market by ... Compliance, and Governance), by Organization Size, by Deployment, by ... published by MarketsandMarkets, The market is estimated to grow ... Billion by 2020, at a Compound Annual Growth Rate ...
(Date:3/9/2016)... March 9, 2016 Nigeria ... that more than 23,000 public service employees either did ... receiving their salary unlawfully.    --> ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ...
Breaking Biology News(10 mins):